WOOJUNG BIO to Change Name to Kolmar BioTech and Diversify Business, Convening EGM
WOOJUNG BIO will hold an extraordinary general meeting on July 8, 2026 to approve changing its corporate name to Kolmar BioTech, Inc. and adding new business purposes such as cosmetic raw materials, pharmaceutical intermediates, and animal health products.
The meeting also includes the appointment of inside director Ham Seok-hee, current HR director, and amendments to the executive retirement pay regulations.
The name change and business expansion are seen as strategic moves to strengthen ties with the Kolmar group and enter the bio-cosmetics raw material sector.
The company is also refinancing a loan from Industrial Bank of Korea to stabilize its financial structure.
[AI Summary]WOOJUNG BIO's transformation into a Kolmar affiliate with business diversification does not involve share issuance or dilution, limiting near-term shareholder impact. The focus shifts to the execution of new business lines for long-term value creation.